← Back to Clinical Trials
Recruiting NCT06551311

NCT06551311 The Effects of Eccentric Cycling Exercise Program in Chronic Kidney Disease Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06551311
Status Recruiting
Phase —
Sponsor National Cheng Kung University
Condition Chronic Kidney Disease
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2023-07-01
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 55 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
cycling training exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2023-07-01 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Progress in medical technology, enhancements in environmental cleanliness, and elevated living conditions have notably prolonged the mean life expectancy, resulting in a swift increase in the aging population. The prevalence of Chronic Kidney Disease (CKD) is more pronounced among the elderly in contrast to younger demographics. With the aging of the CKD population, the capacity to autonomously handle daily activities becomes a critical concern. This demographic frequently encounters concurrent health conditions, a decrease in self-care capabilities, general health decline, and diminished quality of life. Recent studies suggest that physical activity has the potential to enhance cardiovascular health, cardiopulmonary endurance, muscle strength, quality of life, uremic toxin management, and inflammation levels among individuals with CKD. Given that CKD patients often exhibit sedentary behavior and reduced exercise capacity, eccentric cycling exercises may be particularly well-suited for this demographic. Compared to concentric contractions, eccentric contractions subject the muscles to higher tension. Since muscle growth partially depends on the "stress exerted on muscle fibers"-meaning the greater the stress, the more stimulation the muscles receive-training focused on eccentric contractions could provide more stimulation and promote greater muscle growth. In recent studies, eccentric cycling has emerged as a feasible and promising aerobic exercise intervention. It can provide a safe and appropriate amount of exercise while relatively reducing joint pressure. This novel combined aerobic and anaerobic exercise method is particularly beneficial for individuals with weaker lower limb muscles, lower joint pressure tolerance, poor metabolic and cardiovascular function, and a tendency to fatigue.

Eligibility Criteria

This study will be conducted in collaboration with the Departments of Nephrology and Geriatric Medicine at National Cheng Kung University Hospital, Taiwan. Participants will be recruited as voluntary subjects from outpatient clinics. The attending physician will assess eligible patients. After the study's purpose and methodology are explained by the research staff and patients consent to participate, block randomization will be used to assign participants into one of three groups randomly. The allocation results will be securely stored by the principal investigator. Inclusion Criteria: * (1) Clinical diagnosis of CKD * (2) eGFR \<60 ml/min/1.73m\^2 or undergoing routine dialysis * (3) Must be able to communicate normally, understand and comply with instructions. * (4) Must be able to walk independently. Exclusion Criteria: * (1) Clinical diagnosis of acute renal failure * (2) Hospitalization for acute illness within the past three months * (3) Clinical diagnosis of severe joint disease and lower extremity surgery * (4) Clinical diagnosis of severe neurological disease * (5) Clinical diagnosis of severe cardiovascular disease * (6) Unconsciousness or lack of ability to cooperate with the assessment

Contact & Investigator

Central Contact

Kun-Ling Tsai, Ph.D.

✉ kunlingtsai@mail.ncku.edu.tw

📞 886-6-2353535 Ext. 6219

Frequently Asked Questions

Who can join the NCT06551311 clinical trial?

This trial is open to participants of all sexes, aged 55 Years or older, up to 85 Years, studying Chronic Kidney Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06551311 currently recruiting?

Yes, NCT06551311 is actively recruiting participants. Contact the research team at kunlingtsai@mail.ncku.edu.tw for enrollment information.

Where is the NCT06551311 trial being conducted?

This trial is being conducted at Tainan, Taiwan.

Who is sponsoring the NCT06551311 clinical trial?

NCT06551311 is sponsored by National Cheng Kung University. The trial plans to enroll 90 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology